Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherry Li

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Future Oncology (London, England)|May 5, 2020
Angiogenic and immunomodulatory biomarkers in axitinib-treated patients with advanced renal cell carcinomaDanielle A Murphy, Brian I Rini, Bernard Escudier, et al.
Journal of Environmental Sciences (China)|August 14, 2016
Corrigendum to "Development and characterization of monoclonal antibodies against human aryl hydrocarbon receptor" [J. Environ. Sci. 39 (2016) 165-174]Wenjing Tian, Xinhui Pei, Heidi Qunhui Xie, et al.
Future Oncology (London, England)|May 16, 2019
Pharmacogenomic analyses of sunitinib in patients with pancreatic neuroendocrine tumorsNicola Fazio, Jean-Francois Martini, Adina E Croitoru, et al.
Nature Communications|November 13, 2025
Vascularization of neonatal liver lobules presages adult liver sizeD Berfin Azizoglu, Karina Perez, Sherry Li Zheng, et al.
Analytical Chemistry|June 17, 2017
Orthogonal Mass Spectrometry-Based Footprinting for Epitope Mapping and Structural Characterization: The IL-6 Receptor upon Binding of Protein TherapeuticsKe Sherry Li, Guodong Chen, Jingjie Mo, et al.
Clinical Pharmacokinetics|August 3, 2025
A Phase IIa, Single-Blind, Placebo-Controlled, Parallel-Group Study to Assess Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Brensocatib in Adults with Cystic FibrosisMichael W Konstan, James J Tolle, Emily DiMango, et al.
Breast Cancer Research and Treatment|October 18, 2012
Phase II open-label study of sunitinib in patients with advanced breast cancerDenise A Yardley, E Claire Dees, Stephen D Myers, et al.
STAR Protocols|January 26, 2025
Protocol for the generation of HLF+ HOXA+ human hematopoietic progenitor cells from pluripotent stem cellsSherry Li Zheng, Jonas L Fowler, Julie Y Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2014
A phase I study of PF-04449913, an oral hedgehog inhibitor, in patients with advanced solid tumorsAndrew J Wagner, Wells A Messersmith, M Naveed Shaik, et al.
Nature Communications|November 19, 2023
Nanoscale patterning of collagens in C. elegans apical extracellular matrixJennifer R G Adams, Murugesan Pooranachithra, Erin M Jyo, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Future Oncology (London, England)|May 5, 2020
Angiogenic and immunomodulatory biomarkers in axitinib-treated patients with advanced renal cell carcinomaDanielle A Murphy, Brian I Rini, Bernard Escudier, et al.
Journal of Environmental Sciences (China)|August 14, 2016
Corrigendum to "Development and characterization of monoclonal antibodies against human aryl hydrocarbon receptor" [J. Environ. Sci. 39 (2016) 165-174]Wenjing Tian, Xinhui Pei, Heidi Qunhui Xie, et al.
Future Oncology (London, England)|May 16, 2019
Pharmacogenomic analyses of sunitinib in patients with pancreatic neuroendocrine tumorsNicola Fazio, Jean-Francois Martini, Adina E Croitoru, et al.
Nature Communications|November 13, 2025
Vascularization of neonatal liver lobules presages adult liver sizeD Berfin Azizoglu, Karina Perez, Sherry Li Zheng, et al.
Analytical Chemistry|June 17, 2017
Orthogonal Mass Spectrometry-Based Footprinting for Epitope Mapping and Structural Characterization: The IL-6 Receptor upon Binding of Protein TherapeuticsKe Sherry Li, Guodong Chen, Jingjie Mo, et al.
Clinical Pharmacokinetics|August 3, 2025
A Phase IIa, Single-Blind, Placebo-Controlled, Parallel-Group Study to Assess Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Brensocatib in Adults with Cystic FibrosisMichael W Konstan, James J Tolle, Emily DiMango, et al.
Breast Cancer Research and Treatment|October 18, 2012
Phase II open-label study of sunitinib in patients with advanced breast cancerDenise A Yardley, E Claire Dees, Stephen D Myers, et al.
STAR Protocols|January 26, 2025
Protocol for the generation of HLF+ HOXA+ human hematopoietic progenitor cells from pluripotent stem cellsSherry Li Zheng, Jonas L Fowler, Julie Y Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2014
A phase I study of PF-04449913, an oral hedgehog inhibitor, in patients with advanced solid tumorsAndrew J Wagner, Wells A Messersmith, M Naveed Shaik, et al.
Nature Communications|November 19, 2023
Nanoscale patterning of collagens in C. elegans apical extracellular matrixJennifer R G Adams, Murugesan Pooranachithra, Erin M Jyo, et al.
Pageof 5